Daimon, T., Kosaka, T., Hongo, H., Aimono, E., Nakamura, K., Mikami, S., . . . Oya, M. (2021). Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification. IJU Case Rep.

Daimon, Tatsuaki, Takeo Kosaka, Hiroshi Hongo, Eriko Aimono, Kohei Nakamura, Shuji Mikami, Hiroshi Nishihara, und Mototsugu Oya. "Prominent Response to Platinum‐based Chemotherapy in a Patient With BRCA2 Mutant‐neuroendocrine Prostate Cancer and MDM2 Amplification." IJU Case Rep 2021.

Daimon, Tatsuaki, et al. "Prominent Response to Platinum‐based Chemotherapy in a Patient With BRCA2 Mutant‐neuroendocrine Prostate Cancer and MDM2 Amplification." IJU Case Rep 2021.